{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:34:58Z","timestamp":1762353298070,"version":"3.37.3"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T00:00:00Z","timestamp":1680220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"crossref"}]},{"name":"AstraZeneca"},{"DOI":"10.13039\/100004331","name":"Johnson & Johnson","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Dairy Council"},{"DOI":"10.13039\/100015302","name":"Ortho Clinical Diagnostics","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015302","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100016545","name":"Roche Diagnostics","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016545","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Siemens Healthcare Diagnostics"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Glycated albumin (GA) is a short-term measure of glycemic control. Several studies have demonstrated an inverse association between body mass index (BMI) and GA, which may affect its performance as a biomarker of hyperglycemia. We investigated cross-sectional associations between GA and multiple measures of adiposity, and compared its performance as a glycemic biomarker by obesity status, in a nationally representative sample of US adults.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We measured GA in adults from the 1999\u20132004 National Health and Nutrition Examination Survey. Separately in adults with and without diabetes, we assessed associations of GA with adiposity measures (BMI, waist circumference, trunk fat, total body fat, and fat mass index) in sex-stratified multivariable regression models. We compared sensitivity and specificity of GA to identify elevated hemoglobin A1c (HbA1c), by obesity status.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In covariate-adjusted regression models, all adiposity measures were inversely associated with GA in adults without diabetes (\u03b2=\u22120.48 to \u22120.22%-point GA per 1 SD adiposity measure; n = 9750) and with diabetes (\u03b2=\u22121.73 to \u22120.92%-point GA per SD). Comparing adults with vs without obesity, GA exhibited lower sensitivity (43% vs 54%) with equivalent specificity (99%) to detect undiagnosed diabetes (HbA1c \u2265 6.5%). Among adults with diagnosed diabetes (n = 1085), GA performed well to identify above-target glycemia (HbA1c \u2265 7.0%), with high specificity (&amp;gt;80%) overall but lower sensitivity in those with vs without obesity (81% vs 93%).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Inverse associations between GA and adiposity were present in people with and without diabetes. GA is highly specific but may not be sufficiently sensitive for diabetes screening in adults with obesity.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jalm\/jfad004","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T05:41:55Z","timestamp":1680241315000},"page":"751-762","source":"Crossref","is-referenced-by-count":4,"title":["Inverse Associations between Measures of Adiposity and Glycated Albumin in US Adults, NHANES 1999\u20132004"],"prefix":"10.1093","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2321-0188","authenticated-orcid":false,"given":"Valerie K","family":"Sullivan","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health , Baltimore, MD , United States"},{"name":"Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University , Baltimore, MD , United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amelia S","family":"Wallace","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health , Baltimore, MD , United States"},{"name":"Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University , Baltimore, MD , United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5607-4848","authenticated-orcid":false,"given":"Mary R","family":"Rooney","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health , Baltimore, MD , United States"},{"name":"Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University , Baltimore, MD , United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8279-6353","authenticated-orcid":false,"given":"Sui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health , Baltimore, MD , United States"},{"name":"Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University , Baltimore, MD , United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health , Baltimore, MD , United States"},{"name":"Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University , Baltimore, MD , United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert H","family":"Christenson","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Maryland School of Medicine , Baltimore, MD , United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6923-7151","authenticated-orcid":false,"given":"Elizabeth","family":"Selvin","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health , Baltimore, MD , United States"},{"name":"Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University , Baltimore, MD , United States"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,3,31]]},"reference":[{"key":"2023070504541856100_jfad004-B1","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s11892-014-0548-3","article-title":"Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management","volume":"14","author":"Parrinello","year":"2014","journal-title":"Curr Diab Rep"},{"key":"2023070504541856100_jfad004-B2","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1210\/er.2012-1041","article-title":"Adiposity and insulin resistance in humans: the role of the different tissue and cellular lipid depots","volume":"34","author":"Hocking","year":"2013","journal-title":"Endocr Rev"},{"key":"2023070504541856100_jfad004-B3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1507\/endocrj.K05-137","article-title":"Body mass index negatively influences glycated albumin, but not glycated hemoglobin, in diabetic patients","volume":"53","author":"Koga","year":"2006","journal-title":"Endocr J"},{"key":"2023070504541856100_jfad004-B4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cca.2006.10.013","article-title":"Negative association of obesity and its related chronic inflammation with serum glycated albumin but not glycated hemoglobin levels","volume":"378","author":"Koga","year":"2007","journal-title":"Clin Chim Acta"},{"key":"2023070504541856100_jfad004-B5","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1373\/clinchem.2017.285742","article-title":"Establishment of community-based reference intervals for fructosamine, glycated albumin, and 1,5-anhydroglucitol","volume":"64","author":"Selvin","year":"2018","journal-title":"Clin Chem"},{"key":"2023070504541856100_jfad004-B6","doi-asserted-by":"crossref","first-page":"e000002","DOI":"10.1136\/bmjdrc-2013-000002","article-title":"Comparative associations of diabetes risk factors with five measures of hyperglycemia","volume":"2","author":"Poon","year":"2014","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2023070504541856100_jfad004-B7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cca.2018.05.044","article-title":"Associations of body mass index with glycated albumin and glycated albumin\/glycated hemoglobin A1c ratio in Chinese diabetic and non-diabetic populations","volume":"484","author":"He","year":"2018","journal-title":"Clin Chim Acta"},{"key":"2023070504541856100_jfad004-B8","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.diabres.2005.07.008","article-title":"Glycated albumin is low in obese, non-diabetic children","volume":"71","author":"Nishimura","year":"2006","journal-title":"Diabetes Res Clin Pract"},{"key":"2023070504541856100_jfad004-B9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.diabres.2007.02.021","article-title":"Glycated albumin is low in obese, type 2 diabetic patients","volume":"78","author":"Miyashita","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"key":"2023070504541856100_jfad004-B10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cca.2014.07.035","article-title":"Body mass index negatively regulates glycated albumin through insulin secretion in patients with type 2 diabetes mellitus","volume":"438","author":"Koga","year":"2015","journal-title":"Clin Chim Acta"},{"key":"2023070504541856100_jfad004-B11","doi-asserted-by":"crossref","first-page":"e51098","DOI":"10.1371\/journal.pone.0051098","article-title":"Serum glycated albumin is inversely influenced by fat mass and visceral adipose tissue in Chinese with normal glucose tolerance","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"key":"2023070504541856100_jfad004-B12","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s13340-020-00431-z","article-title":"Visceral adiposity is associated with the discrepancy between glycated albumin and HbA1c in type 2 diabetes","volume":"11","author":"Maruo","year":"2020","journal-title":"Diabetol Int"},{"key":"2023070504541856100_jfad004-B13","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cca.2019.04.001","article-title":"Increasing waist circumference is associated with decreased levels of glycated albumin","volume":"495","author":"Xu","year":"2019","journal-title":"Clin Chim Acta"},{"key":"2023070504541856100_jfad004-B14","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/jalm\/jfab168","article-title":"Glycated albumin in pristine and non-pristine stored samples in the National Health and Nutrition Examination Survey (NHANES) 1999\u20132004","volume":"7","author":"Daya","year":"2022","journal-title":"J Appl Lab Med"},{"author":"National Center for Health Statistics, Centers for Disease Control and Prevention","key":"2023070504541856100_jfad004-B15"},{"author":"National Center for Health Statistics, Centers for Disease Control and Prevention","key":"2023070504541856100_jfad004-B16"},{"key":"2023070504541856100_jfad004-B17","first-page":"1","article-title":"National Health and Nutrition Examination Survey biospecimen program: NHANES III (1988\u20131994) and NHANES 1999\u20132014","volume":"2","author":"McQuillan","year":"2015","journal-title":"Vital Health Stat"},{"key":"2023070504541856100_jfad004-B18","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1177\/193229681100500619","article-title":"Basic performance of an enzymatic method for glycated albumin and reference range determination","volume":"5","author":"Kohzuma","year":"2011","journal-title":"J Diabetes Sci Technol"},{"author":"Centers for Disease Control and Prevention, National Center for Health Statistics","key":"2023070504541856100_jfad004-B19"},{"author":"Centers for Disease Control and Prevention, National Center for Health Statistics","key":"2023070504541856100_jfad004-B20"},{"key":"2023070504541856100_jfad004-B21","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C\u2013based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"2023070504541856100_jfad004-B22","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.2337\/dc23-S002","article-title":"2. Classification and diagnosis of diabetes: standards of care in diabetes\u20142023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"2023070504541856100_jfad004-B23","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.2337\/dc23-S006","article-title":"6. Glycemic targets: standards of care in diabetes\u20142023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"key":"2023070504541856100_jfad004-B24","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1152\/physrev.00033.2011","article-title":"Pathophysiology of human visceral obesity: an update","volume":"93","author":"Tchernof","year":"2013","journal-title":"Physiol Rev"},{"key":"2023070504541856100_jfad004-B25","first-page":"51S","article-title":"Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults\u2013the evidence report","volume":"6","author":"National Institutes of Health","year":"1998","journal-title":"Obes Res"},{"key":"2023070504541856100_jfad004-B26","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/j.seminhematol.2015.07.006","article-title":"Anemia in clinical practice-definition and classification: does hemoglobin change with aging?","volume":"52","author":"Cappellini","year":"2015","journal-title":"Semin Hematol"},{"author":"National Center for Health Statistics","key":"2023070504541856100_jfad004-B27"},{"key":"2023070504541856100_jfad004-B28","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.atherosclerosis.2015.07.037","article-title":"A comparison of glycated albumin and glycosylated hemoglobin for the screening of diabetes mellitus in Taiwan","volume":"242","author":"Hsu","year":"2015","journal-title":"Atherosclerosis"},{"key":"2023070504541856100_jfad004-B29","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.metabol.2015.03.003","article-title":"Glycated albumin as a diagnostic tool for diabetes in a general Japanese population","volume":"64","author":"Ikezaki","year":"2015","journal-title":"Metabolism"},{"key":"2023070504541856100_jfad004-B30","first-page":"170","article-title":"Factors associated with glycated albumin in adults without diabetes","volume":"94","author":"Freitas","year":"2021","journal-title":"Med Pharm Rep"},{"key":"2023070504541856100_jfad004-B31","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/pedi.13281","article-title":"The performance of glycated albumin as a biomarker of hyperglycemia and cardiometabolic risk in children and adolescents in the United States","volume":"23","author":"Wallace","year":"2021","journal-title":"Pediatr Diabetes"},{"key":"2023070504541856100_jfad004-B32","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.amjcard.2010.02.017","article-title":"Relation of C-reactive protein to abdominal adiposity","volume":"106","author":"Brooks","year":"2010","journal-title":"Am J Cardiol"},{"key":"2023070504541856100_jfad004-B33","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000443691","article-title":"Relations of visceral and abdominal subcutaneous adipose tissue, body mass index, and waist circumference to serum concentrations of parameters of chronic inflammation","volume":"9","author":"Schlecht","year":"2016","journal-title":"Obes Facts"},{"key":"2023070504541856100_jfad004-B34","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/clinchem\/39.4.625","article-title":"Specific glycation of albumin depends on its half-life","volume":"39","author":"Schleicher","year":"1993","journal-title":"Clin Chem"},{"key":"2023070504541856100_jfad004-B35","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0009-9120(91)90586-4","article-title":"Evaluation of the fructosamine test in obesity: consequences for the assessment of past glycemic control in diabetes","volume":"24","author":"Broussolle","year":"1991","journal-title":"Clin Biochem"},{"key":"2023070504541856100_jfad004-B36","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1464-5491.1994.tb00229.x","article-title":"Fructosamine in obese normal subjects and type 2 diabetes","volume":"11","author":"Ardawi","year":"1994","journal-title":"Diabet Med"},{"key":"2023070504541856100_jfad004-B37","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/jps.2600710223","article-title":"Glucosylated albumin and its influence on salicylate binding","volume":"71","author":"Mereish","year":"1982","journal-title":"J Pharm Sci"},{"key":"2023070504541856100_jfad004-B38","doi-asserted-by":"crossref","first-page":"6142","DOI":"10.1016\/S0021-9258(18)32384-6","article-title":"The principal site of nonenzymatic glycosylation of human serum albumin in vivo","volume":"258","author":"Garlick","year":"1983","journal-title":"J Biol Chem"},{"key":"2023070504541856100_jfad004-B39","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/jdi.13383","article-title":"Increased body fat mass reduces the association between fructosamine and glycated hemoglobin in obese type 2 diabetes patients","volume":"12","author":"Verg\u00e8s","year":"2021","journal-title":"J Diabetes Investig"},{"key":"2023070504541856100_jfad004-B40","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1373\/clinchem.2010.150250","article-title":"Determining stability of stored samples retrospectively: the validation of glycated albumin","volume":"57","author":"Nathan","year":"2011","journal-title":"Clin Chem"}],"container-title":["The Journal of Applied Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jalm\/article-pdf\/8\/4\/751\/50778349\/jfad004.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jalm\/article-pdf\/8\/4\/751\/50778349\/jfad004.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T07:36:56Z","timestamp":1688542616000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jalm\/article\/8\/4\/751\/7097475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,31]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,3,31]]},"published-print":{"date-parts":[[2023,7,5]]}},"URL":"https:\/\/doi.org\/10.1093\/jalm\/jfad004","relation":{},"ISSN":["2475-7241"],"issn-type":[{"type":"electronic","value":"2475-7241"}],"subject":[],"published-other":{"date-parts":[[2023,7]]},"published":{"date-parts":[[2023,3,31]]}}}